home / stock / sny / sny news


SNY News and Press, Sanofi From 04/28/24

Stock Information

Company Name: Sanofi
Stock Symbol: SNY
Market: NASDAQ
Website: sanofi.com

Menu

SNY SNY Quote SNY Short SNY News SNY Articles SNY Message Board
Get SNY Alerts

News, Short Squeeze, Breakout and More Instantly...

SNY - Learn to Evaluate (SNY) using the Charts

2024-04-28 22:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

SNY - Bristol, Sanofi, Takeda gain positive CHMP recommendations

2024-04-26 14:32:03 ET More on Bristol, Sanofi, Takeda Bristol-Myers Squibb Stock: Gloomy Q1 Earnings Trigger Justified Sell-Off Bristol-Myers Squibb Company (BMY) Q1 2024 Earnings Call Transcript Sanofi 2024 Q1 - Results - Earnings Call Presentation Takeda s...

SNY - These Are The Biotechs Showing Up At The Biggest Cancer Meeting Of The Year (Oral Presentations)

2024-04-25 17:49:16 ET Summary The Annual Meeting of the American Society of Clinical Oncology is a major event for clinicians and researchers in the field of oncology. The plenary session will feature presentations on topics such as esophageal cancer, melanoma, and lung cancer. ...

SNY - Sanofi (SNY) Q1 2024 Earnings Call Transcript

2024-04-25 11:24:10 ET Sanofi (SNY) Q1 2024 Earnings Conference Call April 25, 2024 08:30 AM ET Company Participants Paul Hudson - Chief Executive Officer François-Xavier Roger - Chief Financial Officer Houman Ashrafian - Executive Vice President & Head-...

SNY - AbbVie reports positive results from Rinvoq versus Dupixent study

2024-04-25 11:24:05 ET More on AbbVie AbbVie Q1 Earnings Preview: No Repeat Of Last Year's Q1 Disappointment AbbVie: Through Humira's Crisis Towards Solid Growth AbbVie: Great To Be Proven Wrong - Still Not A Buy AbbVie Q1 Preview: Skyrizi and Rinvoq’s...

SNY - Expected US Company Earnings on Thursday, April 25th, 2024

Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...

SNY - Sanofi Non-GAAP EPS of Euro1.78, revenue of Euro10.46B; reaffirms FY24 business EPS guidance

2024-04-25 01:38:35 ET More on Sanofi: Sanofi: My Top Pick In Big Pharma Sanofi reportedly lining up banks for consumer products spinoff Sanofi succeeds in late-stage trial for blood disorder candidate Read the full article on Seeking Alpha For furthe...

SNY - Sanofi reportedly lining up banks for consumer products spinoff

2024-04-23 13:32:13 ET More on Sanofi Sanofi: My Top Pick In Big Pharma Sanofi (SNY) Barclays 26th Annual Global Healthcare Conference (Transcript) Sanofi (SNY) Leerink Partners Global Biopharma Conference (Transcript) Sanofi succeeds in late-stage trial for ...

SNY - Alto Neuroscience schizophrenia treatment shows good phase 1 results

2024-04-23 13:21:30 ET More on Alto Neuroscience Alto Neuroscience: Potential First-In-Class Approach To Targeting CNS Disorders Stifel, Baird, Jefferies bullish on Alto Neuroscience, cite upcoming data Alto Neuroscience stock rallies 35% following upsized IPO ...

SNY - Sanofi succeeds in late-stage trial for blood disorder candidate

2024-04-23 09:44:51 ET More on Sanofi Sanofi: My Top Pick In Big Pharma Sanofi (SNY) Barclays 26th Annual Global Healthcare Conference (Transcript) Sanofi (SNY) Leerink Partners Global Biopharma Conference (Transcript) Sanofi reportedly settles 4K Zantac case...

Previous 10 Next 10